1. Home
  2. NVAX vs GRPN Comparison

NVAX vs GRPN Comparison

Compare NVAX & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • GRPN
  • Stock Information
  • Founded
  • NVAX 1987
  • GRPN 2008
  • Country
  • NVAX United States
  • GRPN United States
  • Employees
  • NVAX N/A
  • GRPN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • GRPN Advertising
  • Sector
  • NVAX Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • NVAX 1.3B
  • GRPN 1.2B
  • IPO Year
  • NVAX 1995
  • GRPN 2011
  • Fundamental
  • Price
  • NVAX $9.23
  • GRPN $22.55
  • Analyst Decision
  • NVAX Buy
  • GRPN Buy
  • Analyst Count
  • NVAX 7
  • GRPN 4
  • Target Price
  • NVAX $14.29
  • GRPN $31.25
  • AVG Volume (30 Days)
  • NVAX 4.4M
  • GRPN 1.4M
  • Earning Date
  • NVAX 11-11-2025
  • GRPN 11-11-2025
  • Dividend Yield
  • NVAX N/A
  • GRPN N/A
  • EPS Growth
  • NVAX N/A
  • GRPN N/A
  • EPS
  • NVAX 2.54
  • GRPN N/A
  • Revenue
  • NVAX $1,078,718,000.00
  • GRPN $487,747,000.00
  • Revenue This Year
  • NVAX $60.81
  • GRPN $4.78
  • Revenue Next Year
  • NVAX N/A
  • GRPN $10.96
  • P/E Ratio
  • NVAX $3.62
  • GRPN N/A
  • Revenue Growth
  • NVAX 9.22
  • GRPN N/A
  • 52 Week Low
  • NVAX $5.01
  • GRPN $7.75
  • 52 Week High
  • NVAX $13.77
  • GRPN $43.08
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 60.85
  • GRPN 39.95
  • Support Level
  • NVAX $8.32
  • GRPN $21.60
  • Resistance Level
  • NVAX $9.05
  • GRPN $23.94
  • Average True Range (ATR)
  • NVAX 0.41
  • GRPN 1.12
  • MACD
  • NVAX 0.06
  • GRPN 0.29
  • Stochastic Oscillator
  • NVAX 68.06
  • GRPN 44.35

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: